Research And Markets Research And Markets
0 CHECKOUT

Brain Cancer Drugs Market Research Reports

With low survival rates primary brain cancers such as glioblastoma multiforme (the most common and aggressive of malignant brain tumours) are among the deadliest forms of cancer. Drug development activity is therefore intense in this sector, with resulting business development opportunities. Reports in the Brain Cancer section enable you to explore various facets of the industry from a variety of expert viewpoints, including R&D (clinical trials, drug discovery, etc.), competitive landscape, supply and demand, regional markets, regional market analysis, and much more. Show Less Read more

Glioblastoma Multiforme: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis

The prognosis of patients with GBM remains poor as drug developers turn to immunotherapies to provide more effective options. This report addresses the following questions: - What is the current...

Published:  April 2016
Price:  From EURUSDGBP

Anaplastic Astrocytoma Market: By Treatment (Surgery, Radiation, and Chemotherapy) By Molecule Development Phase (Pre-Registration Phase, Clinical Trail Phase) & Geography-Forecast (2014-2021)

Anaplstic astrocytoma is a rare type of malignant brain tumor classified under WHO grade III in pathological classification system for tumors. Astrocytomas are tumors that develop from certain star-shaped...

Published:  January 2016
Price:  From EURUSDGBP

Global Market Report On Methotrexate Hydrate 2016

The Global Market Report on METHOTREXATE HYDRATE (CAS 133073-73-1) provides comprehensive data on METHOTREXATE HYDRATE global and regional markets including Europe, Asia, North America, Latin America,...

Published:  February 2016
Price:  EURUSDGBP

Brain Cancer: Analytical Tool

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals...

Published:  August 2016
Price:  From EURUSDGBP

Neuroendocrine Tumors: Analytical Tool

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals...

Published:  August 2016
Price:  From EURUSDGBP

Global and Chinese Methotrexate disodium salt (CAS 7413-34-5) Industry - 2016

The 'Global and Chinese Methotrexate disodium salt Industry - 2016' is a professional and in-depth study on the current state of the global Methotrexate disodium salt industry with a focus on the Chinese...

Published:  July 2016
Price:  From EURUSDGBP

Everolimus (CAS 159351-69-6) Global and Chinese Market Report - 2016

The 'Global and Chinese Everolimus Industry - 2016' is a professional and in-depth study on the current state of the global Everolimus industry with a focus on the Chinese market. The report provides...

Published:  August 2016
Price:  From EURUSDGBP

Global and Chinese Cisplatin Industry - 2016

The 'Global and Chinese Cisplatin Industry - 2016' is a professional and in-depth study on the current state of the global Cisplatin industry with a focus on the Chinese market. The report provides...

Published:  August 2016
Price:  From EURUSDGBP

Lomustine (CAS 13010-47-4) Global and Chinese Market Report - 2016

The 'Global and Chinese Lomustine Industry - 2016' is a professional and in-depth study on the current state of the global Lomustine industry with a focus on the Chinese market. The report provides...

Published:  August 2016
Price:  From EURUSDGBP

CAS Methotrexate World Consumption Report

This CAS Methotrexate World Consumption Report provides data on the net consumption of CAS 59-05-2 - Methotrexate Substance(s) in each of the countries listed. The Substance(s) covered (Methotrexate...

Published:  September 2016
Price:  EURUSDGBP

CAS Cyclophosphamide World Consumption Report

This CAS Cyclophosphamide World Consumption Report provides data on the net consumption of CAS 50-18-0 - Cyclophosphamide Substance(s) in each of the countries listed. The Substance(s) covered (Cyclophosphamide...

Published:  September 2016
Price:  EURUSDGBP

Target Atlas in Brain Cancer: A Competitive Outlook

Extra value: One year of free online updates included with this product "Target Atlas in Brain Cancer: A Competitive Outlook" helps you to understand the complex world of commercial development in...

Published:  August 2016
Price:  From EURUSDGBP

Metastatic Brain Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Our Report, “Metastatic Brain Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  September 2016
Price:  From EURUSDGBP

Medulloblastoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Our Report, “Medulloblastoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and...

Published:  September 2016
Price:  From EURUSDGBP

Recurrent Glioblastoma Multiforme (GBM)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Our Report, “Recurrent Glioblastoma Multiforme (GBM)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase...

Published:  September 2016
Price:  From EURUSDGBP

Glioblastoma Multiforme (GBM)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Our Report, “Glioblastoma Multiforme (GBM)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  September 2016
Price:  From EURUSDGBP

Malignant Glioma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Our Report, “Malignant Glioma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs...

Published:  September 2016
Price:  From EURUSDGBP

Glioma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Our Report, “Glioma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their...

Published:  September 2016
Price:  From EURUSDGBP

Neuroblastoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Our Report, “Neuroblastoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and...

Published:  September 2016
Price:  From EURUSDGBP

Brain Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Our Report, “Brain Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their...

Published:  September 2016
Price:  From EURUSDGBP
Loading Indicator